Loading insider details...
Beta
Latest Form 4 (Jan 24, 2026): Grant/Award of 200,000 QNCX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 24, 2026 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 200,000 | n/a |
| Jun 23, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 7,548 | $9.1K |
| Feb 11, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 300,000 | n/a |
| Aug 22, 2024 | Quince Therapeutics, Inc. (QNCX) | Purchase | 48,387 | $31.5K |
| Feb 2, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 145,000 | n/a |
| Sep 6, 2023 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 545,000 | n/a |